SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor drug development in depression? Does mismatch negativity have utility for NMDA receptor drug development in depression?

Por um escritor misterioso

Descrição

Rapid antidepressant effects associated with ketamine have shifted the landscape for the
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
NMDA Receptor Modulators – The Liotta Research Group
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
Teste 2nd by Second Digital - Issuu
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
PDF) Using the pharmacology of latent inhibition to model domains
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
The NMDA receptor antagonist ketamine impairs and delays context
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
Coupling of NMDA receptors and TRPM4 guides discovery of
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
Depression and the NMDA receptor/NO/cGMP pathway - ScienceDirect
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
NMDA receptor subunit diversity: impact on receptor properties
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
Ketamine and Other NMDA Antagonists: Early Clinical Trials and
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
Applied Sciences January-1 2021 - Browse Articles
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
GABAA and NMDA receptor density alterations and their behavioral
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
NMDA receptor trafficking in synaptic plasticity and
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
IJMS, Free Full-Text
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
SciELO - Brazil - Does mismatch negativity have utility for NMDA
de por adulto (o preço varia de acordo com o tamanho do grupo)